Literature DB >> 27527500

Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.

Ryan L Brunsing1, Natalie M Schenker-Ahmed1, Nathan S White1, J Kellogg Parsons2, Christopher Kane2, Joshua Kuperman1, Hauke Bartsch1, Andrew Karim Kader2, Rebecca Rakow-Penner1, Tyler M Seibert3, Daniel Margolis4, Steven S Raman4, Carrie R McDonald5, Nikdokht Farid1, Santosh Kesari6, Donna Hansel7, Ahmed Shabaik7, Anders M Dale1,8, David S Karow1.   

Abstract

Restriction spectrum imaging (RSI) is a novel diffusion-weighted MRI technique that uses the mathematically distinct behavior of water diffusion in separable microscopic tissue compartments to highlight key aspects of the tissue microarchitecture with high conspicuity. RSI can be acquired in less than 5 min on modern scanners using a surface coil. Multiple field gradients and high b-values in combination with postprocessing techniques allow the simultaneous resolution of length-scale and geometric information, as well as compartmental and nuclear volume fraction filtering. RSI also uses a distortion correction technique and can thus be fused to high resolution T2-weighted images for detailed localization, which improves delineation of disease extension into critical anatomic structures. In this review, we discuss the acquisition, postprocessing, and interpretation of RSI for prostate MRI. We also summarize existing data demonstrating the applicability of RSI for prostate cancer detection, in vivo characterization, localization, and targeting. LEVEL OF EVIDENCE: 5 J. Magn. Reson. Imaging 2017;45:323-336.
© 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  biomarker; diffusion-weighted imaging; prostate cancer; restriction spectrum imaging

Mesh:

Year:  2016        PMID: 27527500      PMCID: PMC5222783          DOI: 10.1002/jmri.25419

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  72 in total

1.  Diffusion-weighted magnetic resonance imaging detects local recurrence after radical prostatectomy: initial experience.

Authors:  Gianluca Giannarini; Daniel P Nguyen; George N Thalmann; Harriet C Thoeny
Journal:  Eur Urol       Date:  2011-11-24       Impact factor: 20.096

2.  Changes in Epithelium, Stroma, and Lumen Space Correlate More Strongly with Gleason Pattern and Are Stronger Predictors of Prostate ADC Changes than Cellularity Metrics.

Authors:  Aritrick Chatterjee; Geoffrey Watson; Esther Myint; Paul Sved; Mark McEntee; Roger Bourne
Journal:  Radiology       Date:  2015-06-23       Impact factor: 11.105

3.  PIRADS 2.0: what is new?

Authors:  Baris Turkbey; Peter L Choyke
Journal:  Diagn Interv Radiol       Date:  2015 Sep-Oct       Impact factor: 2.630

4.  Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria).

Authors:  Nikdokht Farid; Daniela B Almeida-Freitas; Nathan S White; Carrie R McDonald; Joshua M Kuperman; Abdulrahman A Almutairi; Karra A Muller; Scott R VandenBerg; Santosh Kesari; Anders M Dale
Journal:  J Neurooncol       Date:  2014-08-19       Impact factor: 4.130

5.  Quantitative imaging biomarkers: the application of advanced image processing and analysis to clinical and preclinical decision making.

Authors:  Jeffrey William Prescott
Journal:  J Digit Imaging       Date:  2013-02       Impact factor: 4.056

Review 6.  Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

Authors:  John V Hegde; Robert V Mulkern; Lawrence P Panych; Fiona M Fennessy; Andriy Fedorov; Stephan E Maier; Clare M C Tempany
Journal:  J Magn Reson Imaging       Date:  2013-05       Impact factor: 4.813

7.  Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.

Authors:  Tsutomu Tamada; Teruki Sone; Yoshimasa Jo; Akira Yamamoto; Takenori Yamashita; Naoto Egashira; Shigeki Imai; Masao Fukunaga
Journal:  Radiology       Date:  2008-06-06       Impact factor: 11.105

8.  Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms.

Authors:  S Choudhary; A Rajesh; N J Mayer; K A Mulcahy; A Haroon
Journal:  Clin Radiol       Date:  2009-03-09       Impact factor: 2.350

Review 9.  Prostate cancer risk stratification with magnetic resonance imaging.

Authors:  Ely R Felker; Daniel J Margolis; Nima Nassiri; Leonard S Marks
Journal:  Urol Oncol       Date:  2016-03-31       Impact factor: 3.498

10.  Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM.

Authors:  Nikdokht Farid; Daniela B Almeida-Freitas; Nathan S White; Carrie R McDonald; Karra A Muller; Scott R Vandenberg; Santosh Kesari; Anders M Dale
Journal:  Front Oncol       Date:  2013-09-30       Impact factor: 6.244

View more
  12 in total

Review 1.  Diffusion MRI of cancer: From low to high b-values.

Authors:  Lei Tang; Xiaohong Joe Zhou
Journal:  J Magn Reson Imaging       Date:  2018-10-12       Impact factor: 4.813

2.  Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate Cancer.

Authors:  Ely R Felker; Steven S Raman; Sepideh Shakeri; Sohrab A Mirak; Amirhossein M Bajgiran; Lorna Kwan; Pooria Khoshnoodi; Fuad F ElKhoury; Daniel J A Margolis; David Karow; David S K Lu; Nate White; Leonard S Marks
Journal:  AJR Am J Roentgenol       Date:  2019-04-30       Impact factor: 3.959

Review 3.  Emerging MR methods for improved diagnosis of prostate cancer by multiparametric MRI.

Authors:  Durgesh Kumar Dwivedi; Naranamangalam R Jagannathan
Journal:  MAGMA       Date:  2022-07-22       Impact factor: 2.533

4.  Quantitative diffusion MRI of the abdomen and pelvis.

Authors:  Diego Hernando; Yuxin Zhang; Ali Pirasteh
Journal:  Med Phys       Date:  2021-10-08       Impact factor: 4.506

5.  Diffusion-relaxation correlation spectroscopic imaging: A multidimensional approach for probing microstructure.

Authors:  Daeun Kim; Eamon K Doyle; Jessica L Wisnowski; Joong Hee Kim; Justin P Haldar
Journal:  Magn Reson Med       Date:  2017-03-19       Impact factor: 4.668

Review 6.  Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.

Authors:  Ziren Kong; Chengrui Yan; Ruizhe Zhu; Jiaru Wang; Yaning Wang; Yu Wang; Renzhi Wang; Feng Feng; Wenbin Ma
Journal:  Neuroimage Clin       Date:  2018-07-05       Impact factor: 4.881

7.  Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.

Authors:  Tuva R Hope; Per Selnes; Irena Rektorová; Lubomira Anderkova; Nela Nemcova-Elfmarkova; Zuzana Balážová; Anders Dale; Atle Bjørnerud; Tormod Fladby
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

Review 8.  Evolution of prostate MRI: from multiparametric standard to less-is-better and different-is better strategies.

Authors:  Rossano Girometti; Lorenzo Cereser; Filippo Bonato; Chiara Zuiani
Journal:  Eur Radiol Exp       Date:  2019-01-28

9.  Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer's disease.

Authors:  Emilie T Reas; Donald J Hagler; Nathan S White; Joshua M Kuperman; Hauke Bartsch; Karalani Cross; Richard Q Loi; Akshara R Balachandra; M J Meloy; Christina E Wierenga; Douglas Galasko; James B Brewer; Anders M Dale; Linda K McEvoy
Journal:  Alzheimers Res Ther       Date:  2017-08-02       Impact factor: 6.982

10.  Precision medicine screening using whole-genome sequencing and advanced imaging to identify disease risk in adults.

Authors:  Bradley A Perkins; C Thomas Caskey; Pamila Brar; Eric Dec; David S Karow; Andrew M Kahn; Ying-Chen Claire Hou; Naisha Shah; Debbie Boeldt; Erin Coughlin; Gabby Hands; Victor Lavrenko; James Yu; Andrea Procko; Julia Appis; Anders M Dale; Lining Guo; Thomas J Jönsson; Bryan M Wittmann; Istvan Bartha; Smriti Ramakrishnan; Axel Bernal; James B Brewer; Suzanne Brewerton; William H Biggs; Yaron Turpaz; J Craig Venter
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.